These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 10469789
1. Thimerosal in vaccines--An interim report to clinicians. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Environmental Health. Pediatrics; 1999 Sep; 104(3 Pt 1):570-4. PubMed ID: 10469789 [No Abstract] [Full Text] [Related]
2. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. Ann Pharmacother; 1999 Sep; 33(9):1021. PubMed ID: 10492513 [No Abstract] [Full Text] [Related]
3. Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (USPHS). Pediatrics; 1999 Sep; 104(3 Pt 1):568-9. PubMed ID: 10469788 [No Abstract] [Full Text] [Related]
5. Recommendations regarding the use of vaccines that contain thimerosal as a preservative. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 1999 Nov 05; 48(43):996-8. PubMed ID: 10577494 [Abstract] [Full Text] [Related]
6. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 1999 Jul 09; 48(26):563-5. PubMed ID: 10418806 [Abstract] [Full Text] [Related]
7. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. Neonatal Netw; 1999 Sep 09; 18(6):65, 72. PubMed ID: 10690100 [No Abstract] [Full Text] [Related]
9. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content. Chang S, Begier EM, Schech SD, Venus P, Shatin D, Braun MM, Ball R. Pediatr Infect Dis J; 2007 Apr 09; 26(4):329-33. PubMed ID: 17414397 [Abstract] [Full Text] [Related]
10. An assessment of thimerosal use in childhood vaccines. Ball LK, Ball R, Pratt RD. Pediatrics; 2001 May 09; 107(5):1147-54. PubMed ID: 11331700 [Abstract] [Full Text] [Related]
12. Early mercury exposure (with ethylmercury) could include 3-day olds: is that the case in China? Dórea JG. Environ Res; 2008 Mar 09; 106(3):420; discussion 421-2. PubMed ID: 18221937 [No Abstract] [Full Text] [Related]
17. Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices. Hurie MB, Saari TN, Davis JP. Pediatrics; 2001 Apr 12; 107(4):755-8. PubMed ID: 11335754 [Abstract] [Full Text] [Related]
18. Mercury in vaccines and developmental problems: the latest research. Child Health Alert; 2007 Oct 12; 25():3. PubMed ID: 18273929 [No Abstract] [Full Text] [Related]
19. National Advisory Committee on Immunization (NACI). Statement on thimerosal. Gemmill I. Can Commun Dis Rep; 2003 Mar 01; 29():1-10. PubMed ID: 12632795 [No Abstract] [Full Text] [Related]